NDC 47335-003 Carbidopa, Levodopa And Entacapone
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 47335 - Sun Pharmaceutical Industries, Inc.
- 47335-003 - Carbidopa, Levodopa And Entacapone
Product Characteristics
BROWN (C48332 - LIGHT BROWNISH RED)
OVAL (C48345)
14 MM
16 MM
T1;75
T1;100
Product Packages
NDC Code 47335-003-88
Package Description: 100 TABLET, FILM COATED in 1 BOTTLE
Price per Unit: $0.85062 per EA
Product Details
What is NDC 47335-003?
What are the uses for Carbidopa, Levodopa And Entacapone?
Which are Carbidopa, Levodopa And Entacapone UNII Codes?
The UNII codes for the active ingredients in this product are:
- CARBIDOPA (UNII: MNX7R8C5VO)
- CARBIDOPA ANHYDROUS (UNII: KR87B45RGH) (Active Moiety)
- LEVODOPA (UNII: 46627O600J)
- LEVODOPA (UNII: 46627O600J) (Active Moiety)
- ENTACAPONE (UNII: 4975G9NM6T)
- ENTACAPONE (UNII: 4975G9NM6T) (Active Moiety)
Which are Carbidopa, Levodopa And Entacapone Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- STARCH, CORN (UNII: O8232NY3SJ)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- GLYCERIN (UNII: PDC6A3C0OX)
- HYPROMELLOSES (UNII: 3NXW29V3WO)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MANNITOL (UNII: 3OWL53L36A)
- POLYSORBATE 80 (UNII: 6OZP39ZG8H)
- POVIDONE (UNII: FZ989GH94E)
- SUCROSE (UNII: C151H8M554)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
What is the NDC to RxNorm Crosswalk for Carbidopa, Levodopa And Entacapone?
- RxCUI: 403850 - carbidopa 12.5 MG / levodopa 50 MG / entacapone 200 MG Oral Tablet
- RxCUI: 403850 - carbidopa 12.5 MG / entacapone 200 MG / levodopa 50 MG Oral Tablet
- RxCUI: 403850 - Carbidopa 12.5 MG / entacapone 200 MG / L-DOPA 50 MG Oral Tablet
- RxCUI: 403851 - carbidopa 25 MG / levodopa 100 MG / entacapone 200 MG Oral Tablet
- RxCUI: 403851 - carbidopa 25 MG / entacapone 200 MG / levodopa 100 MG Oral Tablet
* Please review the disclaimer below.
Patient Education
Entacapone
Entacapone is an inhibitor of catechol-O-methyltransferase (COMT). It is used in combination with levodopa and carbidopa (Sinemet) to treat the end-of-dose 'wearing-off' symptoms of Parkinson's disease. Entacapone helps the levodopa and carbidopa work better by allowing more of it to reach the brain, where it has its effects. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
[Learn More]
Levodopa and Carbidopa
The combination of levodopa and carbidopa is used to treat the symptoms of Parkinson's disease and Parkinson's-like symptoms that may develop after encephalitis (swelling of the brain) or injury to the nervous system caused by carbon monoxide poisoning or manganese poisoning. Parkinson's symptoms, including tremors (shaking), stiffness, and slowness of movement, are caused by a lack of dopamine, a natural substance usually found in the brain. Levodopa is in a class of medications called central nervous system agents. It works by being converted to dopamine in the brain. Carbidopa is in a class of medications called decarboxylase inhibitors. It works by preventing levodopa from being broken down before it reaches the brain. This allows for a lower dose of levodopa, which causes less nausea and vomiting.
[Learn More]
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".